readthroughSign in
CompanyPBLSNasdaqCambridge, MA

Parabilis Medicines, Inc.

Clinical-stage biopharmaceutical company developing Helicons, a class of alpha-helical peptides targeting intracellular proteins.

10-QNov 12Latest SEC filing
Nov 12Latest story